Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Basilea Pharmceutica NA buy Quitte

Start price
€75.33
21.04.16 / 50%
Target price
€79.00
21.10.16
Performance (%)
-13.13%
End price
€65.44
21.10.16
Summary
This prediction ended on 21.10.16 with a price of €65.44. The prediction for Basilea Pharmceutica NA disappointed with a performance of -13.13%. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Basilea Pharmceutica NA - - - -
iShares Core DAX® 1.395% -0.696% 15.472% 15.907%
iShares Nasdaq 100 2.287% 7.501% 34.748% 53.474%
iShares Nikkei 225® 1.617% 2.769% 11.442% 8.194%
iShares S&P 500 0.659% 4.280% 26.778% 45.322%

Comments by Quitte for this prediction

In the thread Basilea Pharmceutica NA diskutieren
Prediction Buy
Perf. (%) -13.13%
Target price 79.000
Change
Ends at 21.10.16

Kampf gegen Hirntumor

Basilea berichtet über Präsentation von Daten zu den klinischen Onkologie-Kandidaten BAL101553 und BAL3833 auf AACR-Tagung

Prediction Buy
Perf. (%) -13.13%
Target price 79.000
Change
Ends at 21.10.16

(Laufzeit überschritten)